Clinical Trials
The following clinical trials are collaborations initiated by the institute.
Hematological Malignancies
-
Onco-PluReceptor + Elranatamab for Relapsed or Refractory Multiple Myeloma
PI: Qaiser Bashir, M.D.
-
PluReceptor NK for Patients with Recurrent or Refractory B-NHL
PI: Yago Nieto, M.D.
Hematological Malignancies and Solid Tumors
-
CD70 CAR CISH/TGFBR2 KO NK
Solid Tumors
-
PRAME TCR-Engineered NK Cells in Patients with Advanced or Metastatic Solid Tumors
PI: Ecaterina Dumbrava, M.D.
Glioblastoma
-
Dual IL13Ra/EGFRv3CAR/IL21 in GBM
PI: Shiao-Pei Weathers, M.D.
Colorectal Cancer
-
TROP2 CAR NK cells Plus cetuximab in CRC
PI: Maria Morelli, M.D.
Other Disease Indications
Give Now
Your gift will help make a tremendous difference.
Research Areas
Find out about the four types of research taking place at MD Anderson.
Subscribe
Get the latest information on our cancer breakthroughs.?